HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Overly Squeamish About Crest Sensi-Stop Strips Claims – NAD

This article was originally published in The Rose Sheet

Executive Summary

P&G emerges largely unscathed from a National Advertising Division dispute regarding claims for Crest Sensi-Stop Strips, which challenger GlaxoSmithKline Consumer Healthcare argued were unsupported, including the product name. NAD determined the firm’s evidence adequate to support claims of immediate relief and protection for up to one month, among other statements made in ads and on product packaging.

You may also be interested in...



Sensodyne ProNamel TV Ad Claim's Accuracy Slips Through Cracks

NAD finds from P&G challenge that Glaxo's US consumer health business provided no evidence to support express and implied claims conveyed in two TV ads featuring animated image of a tooth surface lined with deep and narrow crevices that Sensodyne ProNamel Intensive Enamel Repair fills and heals cracked enamel.

StriVectin Revises Ad With NAD-Approved ‘Clear And Conspicuous’ Disclosure

The National Advertising Division continues work by the FTC in 2014 to crack down on inadequate disclosures, inquiring into a disclaimer used in print advertising for StriVectin Intensive Illuminating Serum. The skin-care firm will use a revised ad going forward that addresses NAD’s concerns about the disclaimer’s placement, clarity and conspicuousness.

Gillette, Energizer Cross Razors Again With NAD Challenges

Razor competitors Gillette and Energizer have each turned to the National Advertising Division to challenge claims made in the other's marketing, and both have been advised to modify advertising for their men's razors.

Related Companies

UsernamePublicRestriction

Register

RS019462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel